NCT01018875 Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01009255 Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01005862 Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00991419 To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden Status COMPLETED Phase PHASE2
NCT00990613 A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin Status COMPLETED Phase PHASE1
NCT00988624 A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) Status COMPLETED Phase PHASE1
NCT00988598 A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00987220 Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid Status COMPLETED Phase N/A
NCT00980785 Studying the Effects of Antihypertensives on Individuals at Risk for Alzheimer's Status COMPLETED Phase PHASE4
NCT00976118 Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00975481 A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users Status COMPLETED Phase PHASE1
NCT00973518 Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG) Status COMPLETED Phase N/A
NCT00968097 Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition Status TERMINATED Phase PHASE1
NCT00966017 Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia Status UNKNOWN Phase N/A
NCT00965835 Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome Status UNKNOWN Phase N/A
NCT00965588 Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00959192 Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2